Search research articles
Contact Us
Filters
Showing results (111-120 of 199) with videos related to
Page
of 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer
Ravi B Parikh, Angel M Cronin, David E Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
Geoffrey R Oxnard, Yelena Y Janjigian, Maria E Arcila, et al.
JCO Precision Oncology
|
May 18, 2022
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse
Ibiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2025
Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial
Oliver Gautschi, Keunchil Park, Benjamin J Solomon, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology
Laurent Dercle, Dana E Connors, Ying Tang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2021
An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans
Laurent Dercle, Binsheng Zhao, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Antonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.
European Radiology
|
September 30, 2020
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
Firas S Ahmed, Laurent Dercle, Gregory V Goldmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2016
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial
Masahiko Yanagita, Amanda J Redig, Cloud P Paweletz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2018
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu, Bryan C Ulrich, Julianna Supplee, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 199) with videos related to
Sort By:
Page
of 20
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer
Ravi B Parikh, Angel M Cronin, David E Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
Geoffrey R Oxnard, Yelena Y Janjigian, Maria E Arcila, et al.
JCO Precision Oncology
|
May 18, 2022
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse
Ibiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2025
Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial
Oliver Gautschi, Keunchil Park, Benjamin J Solomon, et al.
JCO Clinical Cancer Informatics
|
January 18, 2019
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology
Laurent Dercle, Dana E Connors, Ying Tang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2021
An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans
Laurent Dercle, Binsheng Zhao, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
Antonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.
European Radiology
|
September 30, 2020
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
Firas S Ahmed, Laurent Dercle, Gregory V Goldmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2016
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial
Masahiko Yanagita, Amanda J Redig, Cloud P Paweletz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2018
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu, Bryan C Ulrich, Julianna Supplee, et al.
Page
of 20